Moleculin Biotech, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2016
Go back to Moleculin Biotech, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2016| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 2.75 -0.37 (11.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.12 | 52 Week High | $9.58 | |||
| Open | $2.66 | 52 Week Low | $2.34 | |||
| Day High | $2.85 | P/E | N/A | |||
| Day Low | $2.53 | EPS | $-0.34 | |||
| Volume | 11,235,942 | |||||
